Sign in
TCBPW Stock Price, Chart, Stats & News
TC Biopharm (Holdings) Plc
Save
TC Biopharm (Holdings) Plc (TCBPW) does not currently pay a dividend.
1,282
Market cap
–
Current P/E
–
Forward P/E
TCBPW chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | 15.56% |
ROA | -66.13% |
ROE | -391.64% |
D/E | 0.67x |
Interest coverage ratio | – |
TCBPW valuation
P/E | – |
P/S | – |
P/B | 0.00x |
P/CF | -0.00x |
P/FCF | -0.02x |
P/OCF | -0.00x |
PEG | -0.00x |
EV multiple | -0.06x |
About
TC Biopharm (Holdings) Plc is a biopharmaceutical firm currently in the clinical trial phase, dedicated to advancing immunotherapy treatments. Their core approach revolves around an innovative allogeneic gamma delta T cell platform. The company's development portfolio features OmnImmune, an unmodified cell therapy designed to treat acute myeloid leukemia, and ImmuniStim, another unmodified cell therapy undergoing development for COVID-19.
Similar securities
Based on sector and market capitalization
Report issue